Trial
NCT02523092
Use of CXCL9 as a Biomarker of Acthar Efficacy
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Francisco
Collaborators
Mallinckrodt
Condition
Sarcoidosis
Intervention
Acthar gel
Why stopped
sponsor closed study down
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-30